Prostate Cancer
Prostate cancer risk stratification via eNose urine odor analysis: a preliminary report.
March 22, 2024
PI-RADS v2.1 and PSAD for the prediction of clinically significant prostate cancer among patients with PSA levels of 4-10 ng/ml.
March 21, 2024
VOC-based detection of prostate cancer using an electronic nose and ion mobility spectrometry: A novel urine-based approach.
March 21, 2024
Topline/Final Diagnostic Inclusion of Relevant Histologic Findings in Surgical Pathology Reporting of Carcinoma in Prostate Biopsies.
March 21, 2024
Prostate Cancers in the Prostate-specific Antigen Interval of 1.8-3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening Trial.
March 20, 2024
Using joint models for longitudinal and time-to-event data to investigate the causal effect of salvage therapy after prostatectomy.
March 20, 2024
Evaluating relugolix for the treatment of prostate cancer in real-world settings of care: the OPTYX study protocol.
March 19, 2024
Exploring the relation of active surveillance schedules and prostate cancer mortality.
March 19, 2024